Societal perspective has little impact on CEA results in rare diseases

  • PDF / 186,212 Bytes
  • 1 Pages / 595.245 x 841.846 pts (A4) Page_size
  • 24 Downloads / 157 Views

DOWNLOAD

REPORT

73-5503/20/0868-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 12 Dec 2020 No. 868

1

Data Loading...

Recommend Documents
Including rucaparib in US payer formulary has little budget impact

141 4 166KB

Societal Perspective

172 7 31KB

Focusing on rare diseases in China: are we there yet?

169 96 357KB

CEA

161 57 57MB

CEA

177 95 7MB

Genome Editing for Rare Diseases

200 75 2MB

Genetics of Rare Autoimmune Diseases

216 85 4MB

Impact of Microbes on Autoimmune Diseases

148 0 297KB

Impact of Endocrine Disorders on Gastrointestinal Diseases

204 49 9MB

Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network

163 1 2MB

European expert network on rare communicable diseases and other rare diseases linked to mobility and globalisation focus

121 30 573KB

CEA Incremental

154 91 57MB